A hypothesis on the pathogenesis of Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 786, Issue , 1996, Pages 152-168

  Harman, Denham ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; CONFERENCE PAPER; DOWN SYNDROME; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS;

EID: 0029761483     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb39059.x     Document Type: Conference Paper

References (100)

1. KATZMAN, R. 1986. Alzheimer's disease. N. Engl. J. Med. 314: 964-973.
2. GOEDERT, M., J. STRITTMATTER & A. D. ROSES. 1994. Risky apolipoprotein in brain. Nature 372: 45-46.
3. NALBANTOGLU, J., G. LACOSTE-ROYAL & D. GAUVREAU. 1990. Genetic factors in Alzheimer's disease. J. Am. Geriatr. Soc. 38: 564-568.
4. SCHELLENBERG, G. D., T. D. BIRD, E. M. WIJSMAN, H. T. ORR, L. ANDERSON, E. NEMENS, J. A. WHITE, L. BONNYCASTLE, J. L. WEBER, M. E. ALONSO, H. POTTER, L. L. HESTON & G. M. MARTIN. 1992. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258: 668-671.
5. LEVY-LAHAD, E. W., E. M. WIJSMAN, E. NEMENS, L. ANDERSON, K. A. B. GODDARD, J. L. WEBER, T. D. BIRD & G. D. SCHELLENBERG. 1995. A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973.
6. GOATE, A., M-C. CHARTIER-HARLIN, M. MULLAN et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706.
7. MURRELL, J., M. FARLOW, B. GHETTI & M. D. BENSON. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99.
8. KATZMAN, R. & T. SAITOH. 1991. Advances in Alzheimer's disease. FASEB J. 5: 278-286.
9. HAFNER, H. 1990. Epidemiology of Alzheimer's disease. In Alzheimer's Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics. K. Maurer, P. Riederer & H. Beckmann, Eds. 23-29. Springer-Verlag. New York.
10. BAKER, A. C., L-W. KO & J. P. BLASS. 1988. Systemic manifestations of Alzheimer's disease. Age 11: 60-65.
11. FOLSTEIN, M. F. & F. W. BYLSMA. 1994. Noncognitive symptoms of Alzheimer's disease. In Alzheimer's Disease. R. D. Terry, R. Katzmann & K. L. Bick, Eds. 27-48. Raven Press. New York.
12. BERG, L. & J. C. MORRIS. 1994. Diagnosis. In Alzheimer's Disease. R. D. Terry, R. Katzman, & K. L. Bick, Eds. 9-25. Raven Press. New York.
13. TERRY, R. D., E. MASLIAK & L. A. HANSEN. 1994. Structural basis of the cognitive alterations in Alzheimer's disease. In Alzheimer's Disease. R. D. Terry, R. Katzman & K. L. Bick, Eds. 179-196. Raven Press. New York.
14. HARMAN, D. 1995. Free radical theory of aging: Alzheimer's disease pathogenesis. Age 18. 97-119.
15. BRAAK, H. & E. BRAAK. 1990. Morphology of the cerebral cortex in relation to Alzheimer's dementia. In Alzheimer's Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics. K. Maurer, P. Riederer & H. Beckmann, Eds. 85-91. Springer-Verlag. New York.
16. YOUNKIN, S. G. 1995. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37: 287-288.
17. WISNIEWSKI, H. M. & R. D. TERRY. 1973. Morphology of the aging brain, human and animal. Progr. Brain Res. 48: 167-186.
18. PEARSON, R. C. A., M. M. ESIRI, R. W. HIORNS, G. K. WILCOCK & T. P. S. POWELL. 1985. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 82: 4531-4534.
19. HYMAN, B. T., G. W. VAN HOESEN, A. R. DAMASIO & C. L. BARNES. 1984. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170.
20. BALL, M. J., V. HACHINSKI, A. FOX, A. J. KIRSHEN, M. FISMAN, W. BLUME, V. A. KRAL & H. FOX. 1985. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1: 14-16.
21. YANKNER, B. A. & M-M. MESULAM. 1991. β-amyloid and the pathogenesis of Alzheimer's disease. N. Engl. J. Med. 325: 1849-1857.
22. HARDY, J. A. & G. A. HIGGINS. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
23. REGLAND, B. & C-G. GOTTFRIES. 1992. The role of amyloid β-protein in Alzheimer's disease. Lancet 348: 467-469.
24. KOWALL, N. W., M. F. BEAL, J. BUSCIGLIO, L. K. DUFFY & B. A. YANKNER. 1991. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88: 7247-7251.
25. PODLISNY, M. B., D. T. STEPHENSEN, M. P. FROSCH, D. R. TOLAN, I. LIEBERBURG, J. A. CLEMENS & D. J. SELKOE. 1993. Microinjection of synthetic amyloid β-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am. J. Pathol. 142: 17-24.
26. PIKE, C. J., D. BURDICK, A. J. WALENCEWICZ, C. G. GLABE & C. W. COTMAN. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13: 1676-1687.
27. SIMMONS, L. K., P. C. MAY, K. J. TOMASELLI, R. E. RYDEL, K. S. FUSON, E. F. BRIGHAM, S. WRIGHT, I. IIEBERBURG, G. W. BECKER, D. N. BREMS & W. Y. LI. 1994. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45: 373-375.
28. LORENZO, A. & B. A. YANKNER. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91: 12243-12247.
29. SCHUBERT, D., C. BEHL, R. LESLEY, A. BRACK, R. DARGUSCH, Y. SAGARA & H. KIMURA. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92: 1989-1993.
30. BEHL, C., J. B. DAVIS, R. LESLEY & D. SCHUBERT. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-827.
31. LOO, D. T., A. COPANI, C. J. PIKE, E. R. WHITTEMORE, A. J. WALENCEWICZ & C. W. COTMAN. 1993. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad.Sci. USA 90: 7951-7955.
32. BEHL, C., J. DAVIS, G. M. COLE & D. SCHUBERT. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-950.
33. BOJE, K. M. & P. K. ARORA. 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587: 250-256.
34. DAVIES, C. A. & D. M. A. MANN. 1993. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Am. J. Pathol. 143: 1594-1605.
35. MANN, D. M. A. & M. M. ESIRI. 1989. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J. Neurol. Sci. 89: 169-179.
36. DAVIES, P. 1994. Neuronal abnormalities, not amyloid, are the cause of dementia in Alzheimer disease. In Alzheimer's Disease. R. D. Terry, R. Katzman & K. L. Bick, Eds. 327-333. Raven Press. New York.
37. DELAERE, P., C. DUYCKAERTS, C. MASTERS, K. BEYREUTHER, F. PIETTE & J-J. HAUW. 1990. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci. Lett. 116: 87-93.
38. HARMAN, D. 1986. Free radical theory of aging: role of free radicals in the origination and evolution of life, aging, and disease processes. In Free Radicals, Aging, and Degenerative Diseases. J. E. Johnson, Jr., R. Walford, D. Harman & J. Miquel, Eds. 3-49. Alan R. Liss. New York.
39. HARMAN, D. 1994. Aging: prospects for further increases in the functional life span. Age 17: 119-146.
40. HARMAN, D. 1972. The biologic clock: the mitochondria? J. Am. Geriatr. Soc. 28: 145-147.
41. HARMAN, D. 1983. Free radical theory of aging: consequences of mitochondrial aging. Age 6: 86-94.
42. FLEMING, J. E., J. MIQUEL, S. F. COTTRELL, L. S. YENGOYAN & A. C. ECONOMOS. 1982. Is cell aging caused by respiratory dependent injury to the mitochondrial genome? Gerontology 28: 44-53.
43. BANDY, B. & A. J. DAVISON. 1990. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radical Biol. Med. 8: 523-539.
44. SOHAL, R. S. & B. H. SOHAL. 1991. Hydrogen peroxide release by mitochondria increases during aging. Mech. Ageing Dev. 57: 187-202.
45. KU, H-H., U. T. BRUNK & R. S. SOHAL. 1993. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radical Biol. Med. 15: 621-627.
46. KU, H-H. & R. S. SOHAL. 1993. Comparison of mitochondrial pro-oxidant generation and anti-oxidant defenses between rat and pigeon: possible basis of variation in longevity and metabolic potential. Mech. Ageing Dev. 72: 67-76.
47. 2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. Free Radical Res. 21: 317-328.
48. YEN, T-C., Y-S. CHEN, K-L. KING, S-H. YEH & Y-H. WEI. 1989. Liver mitochondrial respiratory functions decline with age. Biochem. Biphys. Res. Commun. 165: 994-1003.
49. TROUNCE, I., E. BYRNE & S. MARZUKI. 1989. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1: 637-639.
50. BOWLING, A. C., E. M. MUTISYA, L. C. WALKER, D. PRICE, L. C. CORK & M. F. BEAL. 1993. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60: 1964-1967.
51. CORTOPASSI, G. A., D. SHIBATA, N-W. SOONG & N. ARNHEIM. 1992. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA 89: 7370-7374.
52. LEE, C. M., S. S. CHUNG, J. M. KACZKOWSKI, R. WEINDRUCH & J. M. AIKEN. 1993. Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J. Gerontol. Biol. Sci. 48: B201-B205.
53. HAYAKAWA, M., S. SUGIYAMA, K. HATTORI, M. TAKASAWA & T. OZAWA. 1993. Age-associated damage in mitochondrial DNA in human hearts. Mol. Cell. Biochem. 119: 95-103.
54. SHOFFNER, J. M. & D. C. WALLACE. 1990. Oxidative phosphorylation diseases: disorders of two genomes. Adv. Hum. Genet. 19: 267-330.
55. BOWERMAN, B. 1995. Determinants of blastomere identity in the early C. elegans embryo. BioEssays 17: 405-414.
56. SULSTON, J. E., E. SCHIERENBERG, J. G. WHITE & J. N. THOMSON. 1983. The embryonic cell lineage of the nematode Caenorhabiditis elegans. Dev. Biol. 100: 64-119.
57. PARKER, JR., W. D., C. M. FILLEY & J. K. PARKS. 1990. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40: 1302-1303.
58. SHOFFNER, J. M., M. D. BROWN, A. TORRONI, M. T. LOTT, M. F. CABELL, S. S. MIRRA, M. F. BEAL, C-C. YANG, M. GEARING, R. SALVO, R. L. WATTS, J. L. JUNCOS, L. A. HANSEN, B. J. CRAIN, M. FAYAD, C. L. RECKFORD & D. C. WALLACE. 1993. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184.
59. LIN, F-H., R. LIN, H. M. WISNIEWSKI, Y-W. HWANG, F. GRUNDKE-IQBAL, G. HEALY-LOUIE & K. IQBAL. 1992. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem. Biophys. Res. Commun. 182: 238-246.
60. STRITTMATTER, W. J., K. H. WEISGRABER, D. Y. HUANG, L-M. DONG, G. S. SALVESEN, M. PERICAK-VANCE, D. SCHMECHEL, A. M. SAUNDERS, D. GOLDGABER & A. D. ROSES. 1993. Binding of human apolipoprotein E to synthetic β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102.
61. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
62. REBECK, G. W., J. S. REITER, D. K. STRICKLAND & B. T. HYMAN. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580.
63. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST. GEORGE-HYSLOP, M. A. PERIACK-VANCE, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACHLAN, M. J. ALBERTS, C. HULETTE, B. CRAIN, D. GOLDGABER & A. D. ROSES. 1993. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
64. GREGG, R. E., L. A. ZECH, E. J. SCHAEFER, D. STARK, D. WILSON & H. W. BREWER, JR. 1986. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78: 815-821.
65. DYRKS, T., E. DYRKS, T. HARTMANN, C. MASTERS & K. BEYREUTHER. 1992. Amyloidogenicity of βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267: 18210-18217.
66. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94.
67. SHERRINGTON, R., E. I. ROGAEV, Y. LIANG et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.
68. PETERSON, C. & J. E. GOLDMAN. 1986. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer's donors. Proc. Natl. Acad. Sci. USA 83: 2758-2762.
69. LEVY-LAHAD, E., W. WASCO, P. POORKAJ, D. M. ROMAND, J. OSHIMA, W. H. PETTINGELL, C-E. YU, P. D. JONDRO, S. D. SCHMIDT, K. WANG, A. C. CROWLEY, Y-H. FU, S. Y. GUENETTE, D. GALAS, E. NEMENS, E. M. WUSMAN, T. D. BIRD, G. D. SCHELLENBERG & R. E. TANZI. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977.
70. L'HERNAULT, S. W. & P. M. ARDUENGO. 1992. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J. Cell Biol. 119: 55-68.
71. MARZELLA, L. & H. GLAUMANN. 1987. Autophagy, microautophagy and crinophagy as mechanisms for protein degradation. In Liposomes: Their Role in Protein Breakdown. H. Glaumann & F. J. Ballard, Eds. 319-366. Academic Press. New York.
72. CAI, X-D., T. E. GOLDE & S. G. YOUKIN. 1993. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514-516.
73. HIGGINS, L. D., J. M. RODEMS, R. CATALANO, D. QUON & B. CORDELL. 1995. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc. Natl. Acad. Sci. USA 92: 4402-4406.
74. MORAN, P. M., L. S. HIGGINS, B. CORDELL & P. C. MOSER. 1995. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Nat. Acad. Sci. USA 92: 5341-5345.
75. OLIVER, C. & A. J. HOLLAND. 1986. Down's syndrome and Alzheimer's disease: a review. Psychol. Med. 16: 307-322.
76. RUMBLE, B., R. RETALLACK, C. HILBICH, G. SIMMS, G. MULTHAUP, R. MARTINS, A. HOCKEY, P. MONTGOMERY, K. BEYREUTHER & C. L. MASTERS. 1988. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 328: 1446-1452.
77. ELROY-STEIN, D. & Y. GRONER. 1988. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn superoxide dismutase - implications for gene dosage effects in Down syndrome. Cell 52: 259-267.
78. ELROY-STEIN, O., Y. BERNSTEIN & Y. GROMER. 1986. Overproduction of human Cu/ Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 5: 615-622.
79. ZEMLAN, F. P., O. J. THIENHAUS & H. B. BOSMANN. 1989. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res. 476: 160-162.
80. SINET, P-M., J. LEJEUNE & H. JEROME. 1979. Trisomy 21 (Down's syndrome): glutathione peroxidase, hexose monophosphate shunt and I. Q. Life Sci. 24: 29-34.
81. GRAVES, A. B., E. WHITE, T. D. KOEPSELL, B. V. REIFLER, G. VAN BELLE, E. B. LARSON & M. RASKING. 1990. The association between head trauma and Alzheimer's disease. Am. J. Epidemiol. 131: 491-501.
82. ROBERTS, G. W., D. ALLSOP & C. BRUTON. 1990. The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatr. 53: 373-378.
83. GUTERMAN, A. & R. W. SMITH. 1987. Neurological sequelae of boxing. Sports Med. 4: 194-210.
84. ROBERTS, G. W., S. M. GENTLEMEN, A. LYNCH & D. I. GRAHAM. 1991. βA4 Amyloid protein deposition in brain after head trauma. Lancet 338: 1422-1423.
85. ADAMS, C. W. M. & C. J. BRUTON. 1989. The cerebral vasculature in dementia pugilistica. J. Neurol. Neurosurg. Psychiatr. 52: 600-604.
86. PARKER, JR., W. D., S. J. BOYSEN & J. K. PARKS. 1989. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26: 719-723.
87. HAAS, R. H., F. NASRIAN, K. NAKANO, D. WARD, M. PAY, R. HILL & C. W. SCULTS. 1995. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann. Neurol. 37: 714-722.
88. SCHAPIRA, A. H. V., J. M. COOPER, D. DEXTER, J. B. CLARK, P. JENNER & C. D. MARSDEN. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54: 823-827.
89. BINDOFF, L. A., M. A. BIRCH-MACHIN, N. E. F. CARTLIDGE, W. D. PARKER, JR. & D. M. TURNBULL. 1991. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J. Neurol. Sci. 104: 203-208.
90. AHLQVIST, G., S. LANDIN & R. WROBLEWSKI. 1975. Ultrastructure of skeletal muscle in patients with Parkinson's disease and upper motor lesions. Lab. Invest. 32: 673-679.
91. AGID, Y. 1991. Parkinson's disease: pathophysiology. Lancet 337: 1321-1327.
92. BRAAK, H. & E. BRAAK. 1990. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary angles, and neurophil threads in the cerebral cortex. J. Neural. Transm. Parkinson's Dis. Dementia Sect. 2: 45-57.
93. HARMAN, D. & D. E. EDDY. 1979. Free radical theory of aging: beneficial effect of adding antioxidants to the maternal mouse diet on life span of offspring: possible explanation of the sex difference in longevity. Age 2: 109-122.
94. JANZEN, E. G. 1984. A critical review of spin trapping in biological systems. In Free Radicals in Biology. Vol. 4. W. A. Pryor, Ed. 115-154. Academic Press. New York.
95. QUINTANILHA, A. T. & L. PACKER. 1977. Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria. Proc. Natl. Acad. Sci. USA 74: 570-574.
96. LUFT, R. 1994. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA 91: 8731-8738.
97. SHOFFNER, J. M. & D. C. WALLACE. 1992. Heart disease and mitochondrial DNA mutations. Heart Dis. Stroke 1: 235-241.
98. ARTS, W. F. M., H. R. SCHOLTE, J. M. BOGAARD, K. F. KERREBUN & I. E. M. LUYT-HOUWEN. 1983. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 2: 581-582.
99. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl. Acad. Sci. USA 81: 3529-3533.
100. 10. Neurology 36: 45-53.